Questo sito usa cookie per fornirti un'esperienza migliore. Proseguendo la navigazione accetti l'utilizzo dei cookie da parte nostra OK Approfondisci

Covid-19 Response Mechanism of the Global Fund to Fight AIDS, Tuberculosis and Malaria

Developing countries, unspecified

Status

Closed

Aid type

Basket funds/pooled funding

Developing countries, unspecified


Location

-

€ 500,000
Committed
€ 500,000
Used

Description

Reorientation of residual funds to contribute to the Response to the Covid-19 pandemic implemented by the Global Fund to Fight AIDS, Tuberculosis and Malaria read more close
Year Committed Used
2020 € 500,000 € 500,000

Agency

Type Name Channel code
Government AICS - Italian Agency for Cooperation and Development 11000

Channel reported

Type Name Channel code
Multilateral Global Fund - Global Fund to Fight AIDS, Tuberculosis and Malaria 47045

Project data

  • IATI IdentifierXM-DAC-6-4-011141-07-2
  • CRS Activity identifier2020000016
  • AID011141/07/2
  • Planned start 2020/10/12
  • Planned End 2021/06/30
  • Actual start 2020/12/28
  • Actual end 2023/04/07
  • Bi/Multilateral Bilateral
  • Status Closed
  • Tied status Untied

Sectors

  • 12264 - COVID-19 control 100.0%

Policy markers

  • Gender Equality not targeted
  • Disaster Risk Reduction(DRR) not targeted
  • Nutrition not targeted
  • Aid to Environment not targeted
  • Participatory Development/Good Governance not targeted
  • Trade Development not targeted
  • Aid Targeting the Objectives of the Convention on Biological Diversity not targeted
  • Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation not targeted
  • Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation not targeted
  • Aid Targeting the Objectives of the Convention to Combat Desertification not targeted

SDGs

  • 3.3 - By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases
  • 3.b - Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all
-
-
-